LifeStance Health (LFST) Receivables - Net (2020 - 2026)

LifeStance Health (LFST) has 7 years of Receivables - Net data on file, last reported at $122.9 million in Q1 2026.

• Quarterly Receivables - Net fell 12.43% year-over-year to $122.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.9 million (down 12.43% YoY) and the FY2025 annual result came in at $95.7 million, down 27.38% from the prior year.
• Receivables - Net rose to $122.9 million in Q1 2026 per LFST's latest filing, from $95.7 million in the prior quarter.
• Across five years, Receivables - Net topped out at $175.9 million in Q1 2024 and bottomed at $95.0 million in Q1 2022.
• The 5-year median for Receivables - Net is $122.9 million (2026), against an average of $127.5 million.
• The widest annual swing landed in 2022, when Receivables - Net soared 66.04%; it then retreated 27.38% in 2025.
• Tracing LFST's Receivables - Net over 5 years: stood at $100.9 million in 2022, then increased by 24.33% to $125.4 million in 2023, then climbed by 5.1% to $131.8 million in 2024, then dropped by 27.38% to $95.7 million in 2025, then grew by 28.43% to $122.9 million in 2026.
• Per Business Quant, the three latest LFST Receivables - Net figures stand at $122.9 million (Q1 2026), $95.7 million (Q4 2025), and $121.1 million (Q3 2025).

Peer Comparison